Post by Evotec

From complexity to scalability: Enabling macrophage therapies at industrial scale Macrophage-based therapies hold significant promise across oncology, fibrosis, and infectious diseases, but translating that promise into real-world treatments requires solving one key challenge: manufacturing at scale. Our latest poster introduces a GMP-ready, automated 3D bioprocess designed to do exactly that, bringing consistency, efficiency, and scalability to iPSC-derived macrophage production. What you’ll learn: 🔹How a closed, xeno-free stirred-tank process supports scalable manufacturing 🔹Why automation and perfusion are critical for reproducibility and yield 🔹A streamlined approach to generating high-purity macrophages 🔹The foundation for industrialized, off-the-shelf macrophage therapies 🔗 𝗙𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗼𝘂𝗿 𝗽𝗿𝗲𝘀𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗮𝘁 𝘁𝗵𝗲 𝗘𝗦𝗔𝗖𝗧 𝗰𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗶𝗻 𝗦𝗮𝗹𝘇𝗯𝘂𝗿𝗴 𝗲𝗮𝗿𝗹𝗶𝗲𝗿 𝘁𝗵𝗶𝘀 𝗺𝗼𝗻𝘁𝗵, 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗽𝗼𝘀𝘁𝗲𝗿 𝗶𝘀 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲: https://okt.to/DxY2hV #CellTherapy #iPSC #Bioprocessing #ESACT